Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Methamphetamine-targeted dendribodies show no toxicity in vitro

May 4, 2011

CPP-109 enters trial for cocaine and alcohol addiction

April 5, 2011

BioDelivery Sciences announces results of FDA meeting on BEMA-delivered buprenorphine/naloxone

March 8, 2011

Aeolus receives U.S. government contract to develop AEOL-10150 for lung ARS

Feb. 17, 2011

Genotype of polymorphic SLC6A4 gene variants modulates effects of cocaine in vitro

Feb. 16, 2011

Nicotinic acetylcholine alpha5 receptor may represent new target of smoking cessation therapies

Feb. 8, 2011

DigiFab approved in Canada to treat digoxin toxicity/overdose

Feb. 1, 2011

CBLB-502 demonstrates direct anticancer effect in preclinical models

Jan. 24, 2011

RiVax receives FDA orphan drug status for prevention of ricin intoxication

Jan. 24, 2011

Histamine H3 receptor antagonist JNJ-39220675 shows promise against alcoholism

Jan. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...